offline
Why Vertex Pharmaceuticals Stock Is Slumping Today
Investors are concerned about Vertex's pipeline after a rare miss in the clinic.
What happened
Shares of rare-disease specialist Vertex Pharmaceuticals (NASDAQ:VRTX) fell by as much as 15.7% in pre-market trading Thursday morning. The biotech's stock is under pressure today due to a worrying safety signal observed in a midstage trial for the small-molecule drug VX-814 as a potential treatment for alpha-1 antitrypsin deficiency (AATD).
...
https://www.fool.com/investing/2020/10/1...ing-today/
![[Bild: VRTXc1dl1432.png]](https://finviz.com/publish/101520/VRTXc1dl1432.png)
Investors are concerned about Vertex's pipeline after a rare miss in the clinic.
What happened
Shares of rare-disease specialist Vertex Pharmaceuticals (NASDAQ:VRTX) fell by as much as 15.7% in pre-market trading Thursday morning. The biotech's stock is under pressure today due to a worrying safety signal observed in a midstage trial for the small-molecule drug VX-814 as a potential treatment for alpha-1 antitrypsin deficiency (AATD).
...
https://www.fool.com/investing/2020/10/1...ing-today/
__________________
